Dr. David E. Kram
Claim this profileWake Forest University Health Sciences
Expert in Brain Tumor
Expert in Tumors
28 reported clinical trials
77 drugs studied
About David E. Kram
Education:
- Obtained MD from Wake Forest University School of Medicine in 1987.
- Completed Residency in Internal Medicine at Wake Forest Baptist Medical Center in 1990.
- Finished Fellowship in Gastroenterology at Wake Forest Baptist Medical Center in 1992.
Experience:
- Currently serves as a Professor of Internal Medicine – Gastroenterology at Wake Forest School of Medicine.
Area of expertise
1Brain Tumor
Global LeaderStage IV
Stage I
Stage II
2Tumors
Global LeaderStage I
Stage II
Stage IV
Affiliated Hospitals
Clinical Trials David E. Kram is currently running
Genetic Testing-Directed Therapy
for Pediatric Cancer
This Pediatric MATCH screening and multi-sub-study phase II trial studies how well treatment that is directed by genetic testing works in pediatric patients with solid tumors, non-Hodgkin lymphomas, or histiocytic disorders that have progressed following at least one line of standard systemic therapy and/or for which no standard treatment exists that has been shown to prolong survival. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with genetic changes or abnormalities (mutations) may benefit more from treatment which targets their tumor's particular genetic mutation, and may help doctors plan better treatment for patients with solid tumors or non-Hodgkin lymphomas.
Recruiting1 award Phase 214 criteria
Selumetinib vs. Chemotherapy
for Brain Cancer
This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.
Recruiting2 awards Phase 3
More about David E. Kram
Clinical Trial Related7 years of experience running clinical trials · Led 28 trials as a Principal Investigator · 12 Active Clinical TrialsTreatments David E. Kram has experience with
- Cyclophosphamide
- Radiation Therapy
- Etoposide
- Vincristine Sulfate
- Dexamethasone
- Pegaspargase
Breakdown of trials David E. Kram has run
Brain Tumor
Tumors
Cancer
Neuroblastoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does David E. Kram specialize in?
David E. Kram focuses on Brain Tumor and Tumors. In particular, much of their work with Brain Tumor has involved Stage IV patients, or patients who are Stage I.
Is David E. Kram currently recruiting for clinical trials?
Yes, David E. Kram is currently recruiting for 10 clinical trials in Winston-Salem North Carolina. If you're interested in participating, you should apply.
Are there any treatments that David E. Kram has studied deeply?
Yes, David E. Kram has studied treatments such as Cyclophosphamide, Radiation Therapy, Etoposide.
What is the best way to schedule an appointment with David E. Kram?
Apply for one of the trials that David E. Kram is conducting.
What is the office address of David E. Kram?
The office of David E. Kram is located at: Wake Forest University Health Sciences, Winston-Salem, North Carolina 27157 United States. This is the address for their practice at the Wake Forest University Health Sciences.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.